Rhumbline Advisers lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.7% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,588,486 shares of the healthcare conglomerate's stock after selling 10,685 shares during the quarter. UnitedHealth Group accounts for 0.8% of Rhumbline Advisers' portfolio, making the stock its 17th biggest position. Rhumbline Advisers owned 0.18% of UnitedHealth Group worth $831,971,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Aletheian Wealth Advisors LLC raised its holdings in shares of UnitedHealth Group by 9.4% during the first quarter. Aletheian Wealth Advisors LLC now owns 999 shares of the healthcare conglomerate's stock valued at $523,000 after acquiring an additional 86 shares in the last quarter. Bowman & Co S.C. lifted its position in shares of UnitedHealth Group by 16.0% in the 1st quarter. Bowman & Co S.C. now owns 4,566 shares of the healthcare conglomerate's stock worth $2,399,000 after purchasing an additional 630 shares during the period. Sterneck Capital Management LLC purchased a new position in shares of UnitedHealth Group during the first quarter valued at about $207,000. Fifth Third Wealth Advisors LLC lifted its holdings in UnitedHealth Group by 9.9% in the first quarter. Fifth Third Wealth Advisors LLC now owns 14,772 shares of the healthcare conglomerate's stock worth $7,737,000 after buying an additional 1,332 shares during the period. Finally, Cerro Pacific Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 1.4% in the 1st quarter. Cerro Pacific Wealth Advisors LLC now owns 2,334 shares of the healthcare conglomerate's stock worth $1,181,000 after acquiring an additional 33 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
UNH has been the subject of a number of research reports. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Morgan Stanley decreased their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. KeyCorp cut their price target on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research note on Monday. Finally, Oppenheimer dropped their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $428.43.
Check Out Our Latest Stock Report on UNH
UnitedHealth Group Stock Performance
Shares of NYSE:UNH traded down $3.29 during trading on Tuesday, hitting $301.43. The company's stock had a trading volume of 12,704,993 shares, compared to its average volume of 6,860,993. The company has a 50-day moving average of $426.60 and a 200-day moving average of $490.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market cap of $273.44 billion, a price-to-earnings ratio of 19.45, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the firm earned $6.91 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
Insider Buying and Selling at UnitedHealth Group
In related news, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock valued at $31,607,768 over the last 90 days. 0.33% of the stock is currently owned by corporate insiders.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.